{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:26:49Z","timestamp":1781846809179,"version":"3.54.5"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>to establish and quantify any observable association between the exposure to community prescriptions for quinine and acute kidney injury (AKI) events in a population of older adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>two observational studies using the same dataset, a retrospective longitudinal cohort study and a self-controlled case series (SCCS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>NHS health board in Scotland.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>older adults (60+ years) who received quinine prescriptions in Tayside, Scotland, between January 2004 and December 2015. The first study included 12,744 individuals. The SCCS cohort included 5,907 people with quinine exposure and\u00a0more than or equal to one AKI event.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measured<\/jats:title>\n                  <jats:p>in the first study, multivariable logistic regression was used to calculate odds ratios (ORs) for AKI comparing between episodes with and without recent quinine exposure after adjustment for demographics, comorbidities and concomitant medications. The SCCS study divided follow-up for each individual into periods \u2018on\u2019 and \u2018off\u2019 quinine, calculating incidence rate ratios (IRRs) for AKI adjusting for age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>during the study period, 273,596 prescriptions for quinine were dispensed in Tayside. A total of 13,616 AKI events occurred during follow-up (crude incidence 12.5 per 100 person-years). In the first study, exposure to quinine before an episode of care was significantly associated with an increased probability of AKI (adjusted OR\u2009=\u20091.27, 95% confidence interval (CI) 1.21\u20131.33). In the SCCS study, exposure to quinine was associated with an increased relative incidence of AKI compared to unexposed periods (IRR\u2009=\u20091.20, 95% CI 1.15\u20131.26), with the greatest risk observed within 30\u00a0days following quinine initiation (IRR\u2009=\u20091.48, 95% CI 1.35\u20131.61).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>community prescriptions for quinine in an older adult population are associated with an increased risk of AKI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ageing\/afaa079","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T04:05:02Z","timestamp":1585886702000},"page":"1042-1047","source":"Crossref","is-referenced-by-count":5,"title":["Quinine exposure and the risk of acute kidney injury: a population-based observational study of older people"],"prefix":"10.1093","volume":"49","author":[{"given":"Andrew D S","family":"Duncan","sequence":"first","affiliation":[{"name":"Renal Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Hapca","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK"},{"name":"Division of Computing Science and Mathematics, Faculty of Natural Sciences, University of Stirling, Stirling FK9 4LA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicosha","family":"De Souza","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Morales","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9100-1575","authenticated-orcid":false,"given":"Samira","family":"Bell","sequence":"additional","affiliation":[{"name":"Renal Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK"},{"name":"Division of Population Health and Genomics, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"2020102309305593200_ref1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ajkd.2016.05.018","article-title":"Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study","volume":"69","author":"Sawhney","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2020102309305593200_ref2","doi-asserted-by":"crossref","first-page":"h5639","DOI":"10.1136\/bmj.h5639","article-title":"Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery-development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study","volume":"351","author":"Bell","year":"2015","journal-title":"BMJ"},{"key":"2020102309305593200_ref3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ki.2011.405","article-title":"Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury","volume":"81","author":"Bucaloiu","year":"2012","journal-title":"Kidney Int"},{"key":"2020102309305593200_ref4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N Engl J Med"},{"key":"2020102309305593200_ref5","doi-asserted-by":"crossref","first-page":"e019435","DOI":"10.1136\/bmjopen-2017-019435","article-title":"Acute kidney injury in the UK: a replication cohort study of the variation across three regional populations","volume":"8","author":"Sawhney","year":"2018","journal-title":"BMJ Open"},{"key":"2020102309305593200_ref6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2215\/CJN.08970911","article-title":"Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients","volume":"7","author":"Selby","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020102309305593200_ref7","first-page":"23","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2020102309305593200_ref8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/ageing\/afw139","article-title":"A review of nocturnal leg cramps in older people","volume":"45","author":"Rabbitt","year":"2016","journal-title":"Age Ageing"},{"key":"2020102309305593200_ref9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ageing\/23.5.418","article-title":"A general population survey of rest cramps","volume":"23","author":"Naylor","year":"1994","journal-title":"Age Ageing"},{"key":"2020102309305593200_ref10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ki.2015.101","article-title":"Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin\u2013angiotensin system inhibitors in the community increases the risk of acute kidney injury","volume":"88","author":"Dreischulte","year":"2015","journal-title":"Kidney Int"},{"key":"2020102309305593200_ref11","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/jama.2017.2332","article-title":"Association between long-term quinine exposure and all-cause mortality","volume":"317","author":"Fardet","year":"2017","journal-title":"JAMA"},{"key":"2020102309305593200_ref12","article-title":"Serious risks associated with using quinine to prevent or treat nocturnal leg cramps","author":"Derbis","year":"2012","journal-title":"FDA News Heal Prof"},{"key":"2020102309305593200_ref13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ajh.24314","article-title":"Diversity and severity of adverse reactions to quinine: a systematic review","volume":"91","author":"Liles","year":"2016","journal-title":"Am J Hematol"},{"key":"2020102309305593200_ref14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-nouri","year":"2015","journal-title":"Blood"},{"key":"2020102309305593200_ref15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood.V77.2.306.306","article-title":"Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity","volume":"77","author":"Gottschall","year":"1991","journal-title":"Blood"},{"key":"2020102309305593200_ref16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.ajkd.2017.05.023","article-title":"Quinine-induced thrombotic microangiopathy: a report of 19 patients","volume":"70","author":"Page","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2020102309305593200_ref17","volume-title":"High-Performance Procedures 2015","author":"SAS\/STAT\u00ae 14.1 User\u2019s Guide"},{"key":"2020102309305593200_ref18","doi-asserted-by":"crossref","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"2020102309305593200_ref19","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfy187","article-title":"Risk of acute kidney injury following community prescription of antibiotics: self-controlled case series","volume":"34","author":"Rennie","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2020102309305593200_ref20","volume-title":"SAS\u00ae Modeling rates and estimating rates and rate ratios (with confidence intervals)"},{"key":"2020102309305593200_ref21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00005344-199011000-00019","article-title":"Quinidine\/quinine: stereospecific electropysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia","volume":"16","author":"Sheldon","year":"1990","journal-title":"J Cardiovasc Physiol"},{"key":"2020102309305593200_ref22","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1161\/01.CIR.92.10.2944","article-title":"Antiarrhythmic activity of quinine in humans","volume":"92","author":"Sheldon","year":"1995","journal-title":"Circulation"},{"key":"2020102309305593200_ref23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(80)90439-2","article-title":"Alpha adrenergic blocking properties of quinine HCl","volume":"63","author":"Mecca","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"2020102309305593200_ref24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/pds.3746","article-title":"Use of quinine and mortality-risk in patients with heart failure\u2014a Danish nationwide observational study","volume":"24","author":"Gjesing","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2020102309305593200_ref25","article-title":"Quinine: not to be used routinely for nocturnal leg cramps. Drug safety update","author":"Medicines and Healthcare products Regulatory Agency"},{"key":"2020102309305593200_ref26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0035-9203(91)90423-V","article-title":"Pharmacokinetics of quinine in young and elderly subjects","volume":"85","author":"Wanwimolruk","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ageing\/article-pdf\/49\/6\/1042\/33993379\/afaa079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ageing\/article-pdf\/49\/6\/1042\/33993379\/afaa079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T13:31:51Z","timestamp":1603459911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/49\/6\/1042\/5848123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,5,28]]},"published-print":{"date-parts":[[2020,10,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afaa079","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,5,28]]}}}